Lyme & Other Tick-Borne Diseases: Research & Clinical Advances 2023
05 Oct 2023
JACKSON, N.J., Oct. 5, 2023 /PRNewswire/ -- Lyme Disease Association Inc. (LDA) will hold its 22nd annual scientific conference, Lyme & Other Tick-Borne Diseases: Research & Clinical Advances 2023, virtually on October 13-14, 2023. LDA and
Columbia Vagelos College of Physicians and Surgeons are joint providers of the CME conference designed for medical & health professionals & researchers but open to the general public.
Continue Reading
Preview
Source: PRNewswire
Research Education Prevention Patient Support
Preview
Source: PRNewswire
Research Education Prevention Patient Support
The conference features faculty including clinicians and researchers from across US. Topics include Lyme & COVID, Cancer Drug May Help Lyme, Psychedelics, Long-Term Lyme Treatments, Lyme Treatment Trials, Pathogens in Post Mortem Tissue, Mast Cell activation, Alpha-gal, Diagnostics, Eye Screening for Lyme, POTS, and Babesia. Speaker & Topic List:
Brian Fallon, MD, Columbia University, the Conference Co-Director: Lyme Treatment Trials.
Monica Embers, PhD and Liz Horn, PhD, MBI: Identifying Pathogens in Post-Mortem Tissue Through the Lyme Disease Biobank Tissue Pipeline;
Lawrence Afrin, MD: Mast Cell Activation Disease;
John Aucott, MD: Persistent Symptoms of Lyme Disease;
Choukri BenMamoun, PhD: Human babesiosis;
Catherine Brissette, PhD: Lyme Neuroborreliosis;
Scott P Commins, MD, PhD: Alpha-gal Syndrome, Mast Cells and Tick Bites;
Natalie Gukasyan, MD: Psychedelics;
Peter J. Gwynne, PhD: B. Burgdorferi Metabolism;
Alison Hinckley, PhD: Changes to Surveillance for Lyme Disease — United States, 2022;
William V. Padula, OD: Peri-papillary Ischemia as a Potential Screening Biomarker for Early Detection of Tick-Borne Infection;
David Putrino, PT, PhD: Long COVID; Peter Rowe, MD: Managing Orthostatic Intolerance;
Klemen Strle, PhD: Immunology, Disease Pathogenesis, PTLDS,
Paul Trouillas, MD, PhD: Severe forms of Late Neuroborreliosis and of Late Tick-Borne Neurological Disease, Complete Remissions Obtained in These Diseases with Long-Term Treatments
Meghan Catherine Lybecker, PhD: Diagnostics;
Stephen M. Rich, PhD, Professor of Microbiology: Potential New Lyme Treatment Now Inhibiting Cancer Growth.
Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Details/Registration:
https://lymediseaseassociation.org/lda-conferences/2023-overview/
https://lymediseaseassociation.org/
About
Lyme Disease Association,Inc. (LDA): a national non-profit which funds research, education and patient support has awarded 124 research grants across the US; its supported research has been acknowledged in 62 peer-reviewed journals. LDA has provided 274 educational grants, and organized 22 CME Lyme conferences. LDA's LymeAid 4 Kids fund, initiated in conjunction with internationally acclaimed author Amy Tan, has provided over ~$450,000 to aid children getting a diagnosis and treatment.
Media Contact Information: LDA President, Pat Smith, Phone: 888-366-6611 Email: [email protected], https://lymediseaseassociation.org/
SOURCE Lyme Disease Association Inc
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.